Folate, homocysteine and neural tube defects: An overview

Experimental Biology and Medicine

Volumn 226, Issue 4, 2001, Pages 243-270

  Van Der Put, Nathalie M J ^a   Van Straaten, Henny W M ^b   Trijbels, Frans J M ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Folate; Homocysteine; Metabolism; MTHFR; Neural tube defects

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CHOLINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE;

CHEMICAL STRUCTURE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC RISK; HEREDITY; HUMAN; HYPERHOMOCYSTEINEMIA; NEURAL TUBE DEFECT; NEURULATION; PREVALENCE; PRIMARY PREVENTION; SHORT SURVEY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 0034994046     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020122600402     Document Type: Short Survey

References (268)

1. The mechanism of neural tube formation
2. The embryonic development of mammalian neural tube defects
3. Mechanisms of neurulation: Traditional viewpoint and recent advances
4. Neurulation: Coming to closure
5. The neural induction process: Its morphogenetic aspects
6. The organizer factors Chordin and Noggin are required for mouse forebrain development
7. Changes in the shape of the developing vertebrate nervous system analyzed experimentally, mathematically and by computer simulation
8. Cell movements driving neurulation in avian embryos
9. Effect of the notochord on the differentiation of a floor plate area in the neural tube of the chick embryo
10. Notochordal induction of cell wedging in the chick neural plate and its role in neural tube formation
11. The case for floor plate induction by the notochord
12. Quantitative analyses of changes in cell shapes during bending of the avian neural plate
13. Some forces that shape the nervous system
14. Studies on the mechanisms of neurulation in the chick: Morphometric analysis of force distribution within the neuroepithelium during neural tube formation
15. A reexamination of the role of microfilaments in neurulation in the chick embryo
16. Calcium regulation of neural fold formation: Visualization of the actin cytoskeleton in living chick embryos
17. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice
18. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice
19. Neural tube closure in the chick embryo is multiphasic
20. Expansion of surface epithelium provides the major extrinsic force for bending of the neural plate
21. Epidermal ectoderm is required for full elevation and for convergence during bending of the avian neural plate
22. Initial closure of the mesencephalic neural groove in the chick embryo involves a releasing zipping-up mechanism
23. Anterior neural tube closure in the mouse: Fuel for disagreement with the classical theory
24. Intermittent pattern of neural tube closure in two strains of mice
25. Neurulation in the rabbit embryo
26. Bidirectional closure of the rostral neuropore in the human embryo
27. Multi-site neural tube closure in humans and maternal folate supplementation
28. A study of the pattern of prospective somites in the presomitic mesoderm of mouse embryos
29. The development of the human brain, the closure of the caudal neuropore, and the beginning of the secondary neurulation at stage 12
30. Does lumbosacral spina bifida arise by failure of neural folding or by defective canalization?
31. The vertebrate tail bud: Three germ layers from one tissue
32. Histological and ultrastructural studies of secondary neurulation in mouse embryos
33. Neurulation in the normal human embryo
34. Organization and development of the tail bud analyzed with the quail-chick chimaera system
35. Malformations of the nervous system
36. Anencephaly: Its spectrum and relationship to neural tube defects
37. Anencephaly: A review
38. Studies in neural tube defects. II. Pathological findings in a prospectively collected series of anencephalics
39. The changing epidemiology of neural tube defects: United States, 1968-1989
40. Arnold-Chiari malformations
41. The prognosis of encephaloceles
42. Outlook for the child with an encephalocele
43. Parietal cephaloceles: Radiographic and magnetic resonance imaging evaluation
44. Encephalocele und hydrocephalus
45. Chiari III malformations: Imaging features
46. Heterogeneity of neural tube defects in Europe: The significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence
47. Teratothanasia: Prenatal loss of abnormal conceptuses and the prevalence of various malformations during human gestation
48. Studies in neural tube defects. I. Epidemiologic and etiologic aspects
49. Neural tube defects
50. The declining prevalence of anencephalus and spina bifida: It's nature, causes and implications
51. Neural tube defects: Epidemiology
52. Prevalence of neural tube defects in South Australia, 1966-1991: Effectiveness and impact of prenatal diagnosis
53. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991
54. Epidemic waves in the prevalence of anencephaly and spina bifida in New York State
55. Anencephaly in the United Kingdom and Republic of Ireland
56. Sex differences in prevalence of congenital neural defects after periconceptional famine exposure
57. Etiologic heterogeneity of neural-tube defects
58. Clues to the aetiology of neural tube malformations
59. Children of adult survivors with spina bifida cystica
60. The family history of spina bifida cystica
61. Shifting genetic patterns in anencephaly and spina bifida
62. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: Results of a United States study
63. Clinical, genetic, and epidemiological factors in neural tube defects
64. Study of genetics, epidemiology, and vitamin usage in familial spina bifida in the United States in the 1990s
65. Valproic acid and spina bifida
66. Neural tube defects: A review of human and animal studies on the etiology of neural tube defects
67. Folate supplementation and neural tube defects: A review of a public health issue
68. Maternal illness, including fever and medication use as risk factors for neural tube defects
69. Unrecognised epidemic of anencephaly and spina bifida
70. Neural tube defects in 18th century
71. Is myelomcningocele a disappearing disease?
72. The role of folic acid in pregnancy: With particular reference to anaemia, abruption and abortion
73. Folic acid metabolism and human embryopathy
74. Vitamin deficiencies and neural robe defects
75. Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency
76. Possible prevention of neural-tube defects by periconceptional vitamin supplementation
77. Increased risk of recurrence of neural tube defects to mothers on a poor diet and possible benefits of dietary counseling
78. Neural tube defects in hurricane aftermath
79. Risk in spina bifida
80. Double-blind randomised control trial of folate treatment before conception to prevent recurrence of neural-tube defects
81. Can vitamins prevent neural tube defects?
82. Neural-tube detects and vitamins: The need for a randomized clinical trial
83. Apparent prevention of neural tube defects by periconceptional vitamin supplementation
84. Further experience of vitamin supplementation for prevention of neural-tube defect recurrences
85. Neural tube defects: Prevention by vitamin supplementation
86. Neural tube defect recurrence after partial vitamin supplementation
87. Prevention of neural-tube defect recurrences
88. Primary prevention of neural tube detects with folic acid supplementation: Cuban experience
89. Prevention of neural-tube defects: Results of the Medical Research Council vitamin study
90. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
91. Periconceptional use of multivitamins and the occurrence of neural tube defects
92. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
93. Periconceptional folic acid exposure and risk of occurrence neural tube defects
94. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects
95. Dietary folate as a risk factor for neural tube defects, evidence from a case-control study in Western Australia
96. Prevention of neural-tube defects with folic acid in China
97. The absence of a relation between the periconceptional use of vitamins and neural-tube defects
98. Folate and neural tube defects
99. Recente ontwikkelingen in de preventieve gezondheidszorg
100. Folate intake in Europe: Recommended, actual and desired intake
101. Response of red blood cell folate to intervention: Implications for folate recommendations for the prevention of neural tube defects
102. 13C NMR analysis of the use of alternative donors to the tetrahydrofolate-dependent one-carbon pools in Saccharomyces cerevisiae
103. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism
104. Compartimentation of folate-mediated one carbon metabolism in eukaryotes
105. Role of mitochondrial and cytoplasmic serine hydroxymethyltransferase isozymes in de novo purine synthesis in Saccharomyces cerevisiae
106. Folates in the synthesis and catabolism of histidine
107. The regulation of folate and methionine metabolism
108. L-(-)10-formyltetrahydrofolate is the cofactor for glycinamide ribonucleotide transformylase from chicken liver
109. Methylenetetrahydrofolate dehydrogenase-methenyl-tetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase: A multifunctional protein from porcine liver
110. Intestinal absorption and malabsorption of folates
111. Folate absorption and transport
112. Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies
113. The interrelationships among folate, vitamin B12, and methionine metabolism
114. Multiple folate transport systems in L1210 cells
115. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo
116. Receptor-mediated folate accumulation is regulated by the cellular folate content
117. The biological chemistry of folate receptors
118. Characterization of a mutation in the reduced folate carrier in transport defective L1210 murine leukemia cell line
119. Folate-binding proteins
120. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles
121. The folate receptor works in tandem with a Probenecid-sensitive carrier in MA104 cells in vitro
122. Potocytosis: Sequestration and transport of small molecules by caveolae
123. Folate binding proteins. Mechanism for placental and intestinal uptake
124. Cell fractionation and electron microscope studies of kidney folate-binding protein
125. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway
126. Folate receptors
127. Genomic organization of the human folate receptor genes on chromosome 11q13
128. Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytrophoblast and choriocarcinoma cells
129. Structure and regulation of a polymorphic gene encoding folate receptor type γ/γ
130. Identification of a novel folate receptor, a truncated receptor, and receptor type β in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity
131. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: Physiological and clinical implications
132. Enzymatic determinations of folate pools
133. Human cytosolic folylpoly-γ-glutamate synthase
134. Enzymatic synthesis and function of folylpolyglutamates
135. Inherited disorders of folate transport and metabolism
136. Regulation of folate and one-carbon metabolism in mammalian cells. II. Effect of folylpoly-γ-glutamate synthetase substrate specificity and level on folate metabolism and folylpoly-γ-glutamate specificity of metabolic cycles of one-carbon metabolism
137. Regulation of folate and one-carbon metabolism in mammalian cells. III. Role of mitochondrial folylpoly-γ-glutamate synthetase
138. Upstream organization of and multiple transcripts from the human folylpoly-gamma-glutamate synthetase gene
139. Purification and properties of human cytosolic folylpoly-gamma-glutamate synthetase and organization, localization, and differential splicing of its gene
140. Identification of folate binding proteins in rat liver
141. Uptake of oxidized folates by rat liver mitochondria
142. Expression of Escherichia coli folylpolyglutamate synthetase in the Chinese hamster ovary cell mitochondrion
143. Enzymatic synthesis of folylpolyglutamates
144. Regulation of folate and one-carbon metabolism in mammalian cells. I. Folate metabolism in Chinese hamster ovary cells expressing Escherichia coli or human folylpoly-γ-glutamate synthetase activity
145. Folates in tissues and cells
146. Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver
147. Summary. Pteroylpolyglutamate metabolism
148. Determination of folate transport pathways in cultured rat proximal tubule cells
149. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects
150. Folate levels and neural tube defects: Implications for prevention
151. The role of nutrition in neural tube defects
152. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?
153. Homocysteine metabolism in pregnancies complicated by neural-tube defects
154. Altered folate and vitamin B12 metabolism in families with spina bifida offspring
155. Is disordered folate metabolism the basis for the genetic predisposition to neural-tube defects?
156. Possible abnormalities of folate and vitamin B12 metabolism associated with neural-tube defects
157. Investigation of factors influencing folate status in women who have had a neural tube defect-affected infant
158. Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects
159. Folic acid absorption in women with a history of pregnancy with neural tube defects
160. Uptake and utilization of DL-5-[methyl]-14C]tetrahydropteroylmonoglutamate by cultured cytotrophoblasts associated with neural tube defects
161. The methylfolate axis in neural tube defects: In vitro characterisation and clinical investigation
162. Impaired regeneration of monoglutamyl tetrahydrofolate leads to cellular folate depletion in mothers affected by spina bifida pregnancy
163. Methionine metabolism in mammals: Adaptation to methionine excess
164. Methionine metabolism in mammals
165. Methionine adenosyltransferase activity in cultured cells and in human tissues
166. Folic acid metabolism and mechanisms of neural tube defects
167. The biosynthesis of spermidine and spermine from putrescine and methionine
168. Disorders of transsulfuration
169. Disorder of homocysteine metabolism
170. N5-Methyltetrahydrofolate-homocysteine methyltransferases
171. Betaine-homocysteine methyltransferase: Organ distribution in man, pig and rat and subcellular distribution in rat
172. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism
173. Methionine metabolism in mammals: Distribution of homocysteine between competing pathways
174. The regulation of homocysteine metabolism
175. Homocysteine metabolism in endothelial cells of a patient homozygous for cystathionine β-synthase (CS) deficiency
176. Methionine and cysteine kinetics at different intakes of cystine in healthy adult men
177. Methionine and cysteine kinetics at different intakes of methionine and cystine in elderly men and women
178. Inhibitors of S-adenosylhomocysteine hydrolase and their role in the regulation of biological methylation
179. Evidence for heme-mediated redox regulation of human cystathionine β-synthase activity
180. Neural-tube defects and derangement of homocysteine metabolism
181. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
182. Risk of neural tube defect-affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5-methyltetrahydrofolate: Homocysteine methyl-transferase
183. Neural tube defects and craniofacial defects with special emphasis on folate pathway genes
184. Molecular genetic analysis of human folate receptors in neural tube defects
185. Lack of association between mutations in the folate receptor-alpha gene and spina bifida
186. Defects in auxiliary redox proteins leads to functional methionine synthase deficiency
187. Purification of soluble cytochrome b5 as a component of the reductive activation of porcine methionine synthase
188. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria
189. Assignment of the gene for cystathionine β-synthase to human chromosome 21 in somatic cell hybrids
190. The gene for cystathionine β-synthase (CBS) maps to the subtelomeric region on chromosome 21q and to the proximal mouse chromosome 17
191. Human cystathionine β-synthase cDNA: Sequence, alternative splicing and expression in cultured cells
192. The human cystathionine β-synthase (CBS) gene: Complete sequence, alternative splicing and polymorphisms
193. Spatial and temporal expression of the cystathionine beta-synthase gene during early human development
194. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine
195. Are common mutations of cystathionine β-synthase involved in the aetiology of neural tube defects?
196. Folate metabolism in pregnancy
197. Cloning, mapping and RNA analysis of the human methionine synthase gene
198. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders
199. Defects in human methionine synthase in cblG patients
200. Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency
201. Mechanism of action of cystathionine β-synthase
202. Folate-vitamin B12 interrelationships in the central nervous system
203. The relationship between vitamin B12 and folic acid and the effect of methionine on folate metabolism
204. Vitamin B12 and anencephaly
205. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects
206. Transcobalamins in the etiology of neural tube defects
207. Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects
208. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects
209. Amniotic fluid B12 and folate levels associated with neural tube defects
210. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid
211. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease
212. Methionine synthase and neural tube defects
213. Genetic polymorhisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects
214. Methionine synthase: High-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects
215. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations
216. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida
217. Feedback inhibition of methylenetetrahydrofolate reductase in rat liver by S-adenosylmethionine
218. Interactions of pig liver methylenetetrahydrofolate reductase with methylenetetrahydropteroyl polyglutamate substrates and with dihydropteroylpolyglutamate inhibitors
219. Are the redox properties of tetrahydrofolate cofactors utilized in folate-dependent reactions?
220. Methylenetetrahydrofolate reductase: Studies in a human mutant and mammalian liver
221. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification
222. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)
223. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency
224. Thermolabile methylenetetrahydrofolate reductase: An inherited risk-factor for coronary artery disease
225. A candidate genetic risk-factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
226. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
227. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages
228. Decreased methylenetetrahydrofolate reductase activity due to the C677T mutation in families with spina bifida offspring
229. Mutated methylenetetrahydrofolate reductase in sporadic and hereditary spina bifida offspring
230. Is the common C677T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis
231. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects
232. C677T homozygosity associated with thermolabile 5,10-methylenetetrahydrofolate reductase as a risk factor for neural tube defects
233. Spina bifida, C677T mutation, and role of folate
234. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy
235. Methylenetetrahydrofolate reductase and neural tube defects
236. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase
237. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects
238. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida
239. Folate status, homocysteine metabolism, and methylenetetrahydrofolate reductase in rural South African blacks with a history of pregnancy complicated by neural tube defects
240. MTHFR C677T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease
241. Distribution of alleles of the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in familial spina bifida
242. Genetic polymorphism in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects
243. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population
244. The thermolabile variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotype of the embryo and the mother
245. A second common mutation in the methylenetetrahydrofolate reductase gene: A risk factor for neural tube defects?
246. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
247. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD)
248. Exploring gene-gene interactions in the etiology of neural tube defects
249. Possible interaction of genotypes at cystathionine beta-synthase (CBS) and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects: NTD Collaborative Group
250. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
251. Folic acid and vitamin B12
252. Stereospecific in vitro embryotoxicity of L-homocysteine in pre- and post-implantation rodent embryos
253. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos
254. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid
255. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development
256. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-affected pregnancies?
257. Methionine and neural tube closure in cultured rat embryos: Morphological and biochemical analyses
258. The role of microfilaments in cranial neurulation in rat embryos: Effects of short-term exposure to cytochalasin D
259. An open cephalic neural tube reproducibly induced by cytochalasin D in rat embryos in vitro
260. Inositol prevents folate-resistant neural tube defects in the mouse
261. Methionine but not folinic acid or vitamin-B12 alters the frequency of neural tube defects in Axd mutant mice
262. Embryonic axial curvature: Relationships to neuropore closure
263. Inherited disorders of folate transport and metabolism
264. Investigation, using rat embryo culture, of the role of methionine supply in folic acid-mediated prevention of neural tube defects